2025 Gross Margin Guidance: Approximately 74%. 2025 Operating Expenses Guidance: Between $133 million and $135 million. Pulmonx Corp (NASDAQ:LUNG) reported a 23% increase in worldwide sales for Q4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback